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Abstract
Background: Coxiella burnetii is the causative agent of Q-fever, a widespread zoonosis. Due to its
high environmental stability and infectivity it is regarded as a category B biological weapon agent.
In domestic animals infection remains either asymptomatic or presents as infertility or abortion.
Clinical presentation in humans can range from mild flu-like illness to acute pneumonia and
hepatitis. Endocarditis represents the most common form of chronic Q-fever. In humans serology
is the gold standard for diagnosis but is inadequate for early case detection. In order to serve as a
diagnostic tool in an eventual biological weapon attack or in local epidemics we developed a real-
time 5'nuclease based PCR assay with an internal control system. To facilitate high-throughput an
automated extraction procedure was evaluated.
Results: To determine the minimum number of copies that are detectable at 95% chance probit
analysis was used. Limit of detection in blood was 2,881 copies/ml [95%CI, 2,188–4,745 copies/ml]
with a manual extraction procedure and 4,235 copies/ml [95%CI, 3,143–7,428 copies/ml] with a
fully automated extraction procedure, respectively. To demonstrate clinical application a total of
72 specimens of animal origin were compared with respect to manual and automated extraction.
A strong correlation between both methods was observed rendering both methods suitable.
Testing of 247 follow up specimens of animal origin from a local Q-fever epidemic rendered real-
time PCR more sensitive than conventional PCR.
Conclusion:  A sensitive and thoroughly evaluated real-time PCR was established. Its high-
throughput mode may show a useful approach to rapidly screen samples in local outbreaks for
other organisms relevant for humans or animals. Compared to a conventional PCR assay sensitivity
of real-time PCR was higher after testing samples from a local Q-fever outbreak.
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Background
Coxiella burnetii (C. burnetii) is an obligate intracellular,
gram negative bacterium. It is the causative agent of Q-
fever. Q-fever is a zoonosis with a worldwide distribution
except New Zealand that affects different animal species
and humans. Clinical presentation in humans ranges
from mild flu-like symptoms to, sometimes, severe atypi-
cal pneumonia and hepatitis [1]. Convalescence can be
slow and endocarditis is the most frequent and serious
manifestation of chronic Q-fever [2]. In animals, prima-
rily cattle, sheep, and goats, C. burnetii can cause abortion
and infertility as it localizes in the female reproductive
system. High doses of C. burnetii have been found in con-
ception products of infected animals. The organism is
shed in the urine, feces and milk of infected animals. In
general infected animals remain asymptomatic. Instead
they often serve as the source of infection for humans via
infective aerosols or contaminated dust [3]. C. burnetii is
very resistant to environmental conditions and can
remain infectious for a considerable time outside the host
cell. Recent outbreaks in France documented the high
environmental stability of the organism when local Q-
fever epidemics were observed weeks after lambing season
[4]. Due to its high infectivity, environmental stability
and its potential to cause severe disease in humans it is
regarded as a category B biological weapon agent by the
Centers for Disease Control and Prevention [5]. Its natural
widespread availability and potential for aerosolized use
makes it considerably suitable as a biological weapon.
Proper administration of antibiotics can significantly
reduce chronic Q-fever associated mortality making
timely diagnosis of utmost importance. For diagnosing C.
burnetii infection serology remains the method of choice
as it is easy to establish and widely applicable. However,
antibodies are detected only after 2–3 weeks from the
onset of disease [6] making it too slow in selected clinical
settings. A capture enzyme-linked immunosorbent assay
(EIA) can be used for direct detection of C. burnetii [7].
However, its high limit of detection significantly reduces
its reliability. Direct detection of C. burnetii is also possi-
ble by cell culture, but this requires biosafety level-three
laboratories. Sensitivity of cell culture is sometimes low
[8]. More recently, PCR has been successfully applied for
the direct detection of C. burnetii in clinical specimens [9].
Though it appears to be highly sensitive, conventional
PCR protocols remain time-consuming due to laborious
post PCR processing, and they are prone to cross-contam-
ination. Modern real-time PCR assays with in tube detec-
tion of amplicons decrease turn around time considerably
[10]. In a bioterrorist event or in the case of local epidem-
ics, masses of samples have to be expected. We have
shown for other agents that real-time PCR provides the
technical prerequisites for high throughput testing [11].
Here we describe a novel 5'nuclease (TaqMan) based real-
time PCR assay for the rapid, sensitive and specific detec-
tion of C. burnetii. A mimic positive control monitors the
reaction under the same conditions as applicable for C.
burnetii, including use of the same primers. It identifies
breaches in sensitivity in each single sample due to insuf-
ficient sample preparation, PCR inhibition or inherent
failure of the PCR itself. To further facilitate high-through-
put application a fully automated extraction procedure
using the BioRobot M48 (Qiagen, Hilden, Germany) was
evaluated and compared to an established manual sample
preparation method.
Results
Coxiella burnetii real-time PCR
Since the transposase gene of C. burnetii is present in
approximately 20 copies per cell it was chosen as the tar-
get sequence. Using Primer Express software two primer
pairs and one 5'nuclease minor groove binder (MGB)
probe were selected. Prepared nucleic acid from a cultured
C. burnetii (Nine mile RSA493) strain was used to opti-
mize the assay. The 86 bp amplicon of the transposase
gene was cloned into E. coli plasmids (pCoxquant), and
used for sensitivity determination. Single copies were
detected in limiting dilution series on an occasional basis.
Constantly positive results were obtained at a concentra-
tion of 15 copies per PCR reaction or more.
To monitor the sensitivity of the assay in each single reac-
tion an internal control mimic DNA was constructed next
[12]. The probe binding site of pCoxquant was deleted
and replaced by an alternative sequence to yield plasmid
pCoxmimic. Its corresponding 5'nuclease probe con-
tained the dye VIC for detection in a separate channel of
the real-time PCR instrument. One copy of the internal
control mimic pCoxmimic was occasionally and 20 cop-
ies constantly detectable. Cross talk into the wild type
channel was not observed. To exclude that the internal
control affected the amplification efficiency of C. burnetii
detection, 15 copies/reaction of pCoxquant were ampli-
fied in the presence of increasing numbers of pCoxmimic.
The cycle threshold (Ct) values for pCoxquant and
pCoxmimic were recorded separately for each target gene
(Figure 1C). The simultaneous amplification of up to 100
copies of internal control did not influence the Ct for
pCoxquant. Only from 700 copies of internal control
onward, variation and delay in Ct  for pCoxquant
occurred. A concentration of 20 copies of pCoxmimic per
reaction was chosen as a working concentration for all fur-
ther experiments, in order to detect even slight drops in
assay sensitivity. The exact limit of detection of real-time
PCR was determined next. Human EDTA blood was
spiked with plasmid pCoxquant in five different concen-
trations. EDTA blood of each concentration was first
extracted manually by means of a QIAmp DNA Mini KitBMC Microbiology 2008, 8:77 http://www.biomedcentral.com/1471-2180/8/77
Page 3 of 8
(page number not for citation purposes)
(Qiagen) in duplicates, and each duplicate was tested in
replicates of 4 (5 × 2 × 4 = 40 reactions). Prior to extrac-
tion the lysis buffer was spiked with pCoxmimic at a con-
centration corresponding to 20 copies per reaction. The
observed proportions of positive results in each concen-
tration were subjected to probit regression analysis (Fig-
ure 1A). 2,881 copies per ml were calculated to be
detectable at ≥95% chance (95%CI, 2,188–4,745). This
corresponded to 14 copies/PCR reaction.
For automated extraction, the Biorobot M48 (Qiagen)
was evaluated exactly in the same manner (Figure 1B).
4,235 (95%CI, 3,143–7,428) copies per ml were calcu-
lated to be detectable with ≥95% chance, corresponding
to 21 copies per PCR.
The internal control pCoxmimic was detected in all sam-
ples including the negative controls. Specificity was evalu-
ated by testing a number of viral and bacterial pathogens
that might be present in human blood samples. None of
the tested pathogens reacted positive with the C. burnetii
Determination of detection limits, amplification efficiency of C. burnetii, correlation of automated and manual extraction Figure 1
Determination of detection limits, amplification efficiency of C. burnetii, correlation of automated and manual 
extraction. Probability of achieving a positive result (y-axis), depending on the DNA input copy number per mL EDTA blood 
(x-axis). A, Qiagen DNA mini kit; B, Qiagen M48 DNA mini kit, used on a Qiagen M48 automated DNA extraction instrument. 
Each datum point represents the rate of positive results in six replicate tests per concentration. Limits of detection are compa-
rable with both methods of DNA extraction. C, Threshold cycles (y-axis) as a measure of efficiency of PCR amplification for C. 
burnetii and internal control. Each reaction contained 15 copies of plasmid-derived C. burnetii target gene and variable numbers 
of internal control plasmid pCoxmimic, as depicted on the x-axis. Results of eight replicate real-time PCR reactions per setting 
are shown as a result of box-plot analysis, showing the range of results by whiskers, whereby the two central quartiles of data 
are represented as a box. Solid line with grey boxes, C. burnetii target gene, broken line with white boxes, internal control. No 
reduced efficiency in amplification is observed for the C. burnetii target gene in presence of up to 100 copies of internal control. 
D, Correlation of C. burnetii DNA copies per ml as determined by C. burnetii real-time PCR after automated (x-axis) and manual 
extraction procedure (y-axis).BMC Microbiology 2008, 8:77 http://www.biomedcentral.com/1471-2180/8/77
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real-time PCR assay (see Methods section). To further
assess the specificity 35 different C. burnetii strains were
subjected to the new real-time assay. As expected all
strains reacted positive (Table 1).
Real-time PCR versus conventional PCR
To further assess the performance of real-time PCR we
finally compared the assay to a conventional PCR. A total
of 247 purified specimens were tested which were sam-
pled during a follow-up study after a local Q-fever epi-
demic in North-Rhine Westphalia. Results are shown in
Table 2 and Figure 2B. The mean Ct value for samples pos-
itive in both assays was 31.31 +/- 2.15 [29.16; 33.46],
which equals 2.7 × 103 copies per PCR (see below). Sam-
ples that were positive by real-time PCR only yielded a
mean Ct of 37.42 +/- 0.81 [36.61; 38.23], which equals 48
copies per PCR. Means were significantly different (t-test,
p ≤ 0.05).
Quantitative real-time PCR
As an example of applicability the novel real-time PCR
assay was evaluated in combination with the manual as
well as the automated extraction procedure on a panel of
samples. Seventy-two homogenized tissue samples were
purified using both extraction methods as described
above. After purification of samples with the manual
extraction method, 27/72 (37.5%) samples yielded a pos-
itive result by real-time PCR. With automated extraction
31/72 (43%) samples tested positive. The mean Ct value
in positive samples for each procedure was 28.2 for the
manual extraction and 27.65 for the automated proce-
dure, respectively (t-test, p = 0.8028). Ct values correlated
proportionally with DNA concentrations, and showed
good accordance between manual and automatic meth-
ods (Figure 1D, correlation coefficient = 0.975).
For absolute quantification a calibration curve was gener-
ated by limiting dilution series of plasmid pCoxquant.
The amplification efficiency calculated from the calibra-
tion curve slope was 0.98, indicating optimal PCR reac-
tion condition. Assuming 20 copies of target gene per
genome, concentrations of C. burnetii per milliliter of
homogenized sample ranged from 9.4 × 104 genomes per
mL to 3.2 × 1010 genomes per ml (470-1.6 × 108 genomes/
reaction).
Cell culture has long been regarded the gold standard for
diagnosing C. burnetii infection. To re-assess its perform-
ance, all 72 samples were also subjected to cell culture.
Only 13 of 72 (18%) samples yielded a positive result by
cell culture. All cell culture positive samples yielded a pos-
itive real-time PCR result irrespective of the purification
method. Again the bacterial concentration per ml sample
was determined and copy numbers of 27 real-time PCR
positive samples were plotted in increasing increments
and compared to cell culture results (Figure 2A). Only
samples with >1 × 108 genomes/ml of homogenized sam-
ple yielded a positive result by cell culture.
Discussion
Recent experience has shown that in the event of a C. bur-
netii epidemic masses of samples are to be expected [13].
We describe here a C. burnetii real-time PCR assay in com-
bination with manual as well as fully automated extrac-
tion procedures for high-throughput use. The assay is
capable of detecting single copies of C. burnetii trans-
posase gene. This target region was chosen because it is
highly conserved among C. burnetii strains and present at
10–30 copies per bacterium, making it an appropriate tar-
get for a diagnostic assay [14-16]. However, despite the
assay was validated on a range of C. burnetii isolates,
strains lacking elements of the transposase gene have been
described [17]. For our calculations of sensitivity we
assumed 20 copies per genome as present in our Nine
Table 1: Characteristics of C. burnetii isolates. Designation, 
geographical origin and host species of C. burnetii isolates testing 
positive by the novel C. burnetii real-time PCR
C. burnetii strain Geographical origin Host species
Nine Mile USA USA Tick
Priscilla USA USA Goat
Scurry USA USA Human
Dugway USA USA Rodent
Z 2775 Germany Cattle
Pohlheim Germany Sheep
Max Germany Sheep
Tiho 1 Germany unknown
Hardthof/90 Germany Cattle
Frankfurt Germany Cattle
Z 104/94 Germany Sheep
München Germany Sheep
OSH-1 Germany Cattle
Bru 180 Germany Cattle
Wdk 1188 Germany Sheep
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Mile RSA 493 reference strain [16]. At 2,881 DNA copies/
ml blood, the analytical sensitivity of our assay was close
to what is possible due to mathematical limitations,
according to the probit model [18]. This sensitivity, corre-
sponding to about 144 genomes per ml, was as high as
with commercial PCR systems available for other bacterial
agents and should be compatible with the reliable detec-
tion of bacteremia [19]. Of note, since the number of cop-
ies of the C. burnetii transposase gene can vary greatly
different sensitivities have to be expected with other
strains.
Due to increased hybridization properties and lower back-
ground fluorescence we decided to use a minor groove
binder (MGB) probe in combination with a non-fluores-
cent-quencher (NFQ) [20]. The use of a NFQ improves
the signal-to-noise ratio and decreases spectral overlap
compared to other fluorescent quencher dyes e.g. TAMRA
[21]. This feature facilitates double dye detection, which
allows implementation of a stable internal control sys-
tem. The internal control was detected in all negative sam-
ples irrespective of the extraction procedure, although
only a low amount of internal control mimic was added
(20 copies plasmid DNA per reaction). Since the internal
control is almost identical to the C. burnetii target gene
including additional positive controls is not necessary.
The advantages of such controls have already been
described and implemented in various assays [22,23].
Besides the PCR itself, the extraction procedure consti-
tutes another crucial factor in molecular diagnostics. It is
the lengthiest part of the whole procedure and automa-
tion is highly desirable especially in a high-throughput
setting. The most valuable advantage of robotic systems is
their speed when numerous samples have to be analyzed
[24]. However, there is little data on the performance of
automated systems in diagnostic settings. In this study the
limit of detection of the automated procedure was only
1.5 times higher than that of the manual protocol (4,235
vs. 2,881 DNA copies/ml blood). Assuming 20 copies per
Bacterial loads in isolation positive samples, box plot analysis of Ct values Figure 2
Bacterial loads in isolation positive samples, box plot analysis of Ct values. A, bacterial loads and C. burnetii isolation 
in real-time PCR positive samples (n = 27). Bacterial loads are shown on the y-axis. "+" in "cell isolation" means isolation suc-
cess as confirmed by detection of inclusion bodies upon microscopy. B, box plot analysis of threshold cycle values in real-time 
PCR positive/conventional negative (n = 32) and real-time PCR positive/conventional PCR positive (n = 38) samples. Difference 
in threshold cycle values are significant (p < 0.05).
Table 2: Results of real-time versus conventional PCR assay. A total of 247 follow up samples of animal origin were analyzed by 
conventional as well as real-time PCR. Numbers of positive and negative results for each PCR assay are shown.
Real-time PCR positive Real-time PCR negative total
PCR positive n = 38 n = 5 n = 43
PCR negative n = 32 n = 172 n = 204
total n = 70 n = 177BMC Microbiology 2008, 8:77 http://www.biomedcentral.com/1471-2180/8/77
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bacterium (Nine mile RSA493 strain) the limit of detec-
tion for the automated procedure was around 210 C. bur-
netii bacteria per ml (1 bacterium per PCR reaction). High
sensitivity and good quantitative correlation with other
extraction methods is in concordance with our earlier
study on the automated extraction of B. anthracis [11].
The novel assay yielded more positive results than con-
ventional PCR upon testing of a large panel of stored sam-
ples of animal origin. However, it should be noted that
2.5 times more template was added to the real-time PCR
reaction. Because PCR negative/real-time PCR positive
samples had significantly lower Ct values than samples
positive in both methods, improved analytical sensitivity
can be assumed for real-time PCR. Of note 5 conventional
PCR positive samples remained repeatedly negative upon
real-time PCR testing. All of these 5 samples were stored
for approximately 3 years at -20°C and reported to be
weakly positive only by conventional PCR. Due to pro-
longed storage it seems likely that some DNA degradation
had happened thus preventing positive results by real-
time PCR.
Critically, classical isolation of C. burnetii by cell culture
showed rather disappointing results. Henning and Sting
have already reported similar results for cell culture [25].
The strain of C. burnetii as well as its source might account
for the here observed rather low number of conventional
cell culture positive results. More sensitive isolation meth-
ods like shell vial technique or inoculation of specimens
into guinea pigs or mice were not available in our labora-
tory. By quantitative PCR we could show that rather high
bacterial loads are necessary for cell culture to become
positive. For this reason and because of the associated bio-
logical risks, cell culture is not the method of choice in the
first run. However, it remains an essential tool for further
pathogen characterization, and allows isolation of related
agents which would go undetected by PCR.
Conclusion
In summary, this assay provides a homogenous tool for
diagnostics in human and veterinary medicine. Since C.
burnetii infection is still not well understood, quantitative
PCR may yield new insights into the pathogenesis of the
disease. Another future field of application of high
throughput assays may comprise the screening of bulk




A cultured C. burnetii (Nine mile RSA493) strain was
kindly donated by D. Raoult, Unite de Rickettsies, Univer-
site de la Mediterranee, Marseille, France.
Samples
To evaluate two different extraction procedures 53 speci-
mens were tested, which were sampled during a local Q-
fever epidemic among sheep in North-Rhine Westphalia/
Germany in 2003. All samples were placenta material. In
addition 19 specimens collected independently by the
Friedrich-Loeffler-Institute (FLI) from different other
sources were analyzed. For specificity testing a panel of 35
C. burnetii strains was tested. In addition, 27 different bac-
teria and viruses which might be present in clinical sam-
ples were obtained from the American Type Culture
Collection (Manassas, VA, USA), the German Collection
of Microorganisms and Cell Cultures (DSMZ, Braunsch-
weig, Germany) or our in house strain collection. For an
additional part of the study 247 aliquots of previously
purified DNA samples from a follow-up examination of
placenta material after the local epidemic of Q-fever in
North-Rhine Westphalia were available.
Cell culture
Isolation of C. burnetii was performed using Buffalo Green
Monkey (BGM) cells. Cells were propagated in 25 cm2
plastic flasks with in UltraCulture medium (BioWitthaker,
Walkersville, Maryland, USA) without supplements.
Material of each sample (1 g) was homogenised using
sterile mortar, sand, and cell culture medium. The super-
natants were filtered through membrane filters (Minisart™
Sartorius, Göttingen, Germany) with pore diameters of
0.2 µm. A volume of 0.5 ml homogenate per flask was
inoculated. Cell cultures were examined weekly by phase-
contrast microscopy for inclusion bodies.
Sample preparation
Samples were first homogenized for cell culture as
described above. For conventional PCR assays nucleic
acids were prepared using the Puregene DNA Blood Isola-
tion Kit (Gentra Systems, Minneapolis, USA). One mL of
the homogenized sample was centrifuged at 12,000 g for
10 min. The pellet was resuspended in 600 µl lysis buffer
and incubated at 80°C for 5 min. Further steps were as
recommended by the manufacturer.
Conventional PCR
A conventional PCR with primers amplifying a 448 bp
product of the transposase gene of C. burnetii (IS1111)
was conducted. Amplification was carried out in a total
reaction volume of 50 µl with 1× PCR Buffer, 2 mM
MgCl2, 200 µM of each dNTP and 0.5 units of Taq
Polymerase (Bioline, Luckenwalde, Germany), 0.5 µM of
primer CoxP4 (ttaaggtgggctgcgtggtgatgg, nt positions
222–245 in GenBank accession M80806) (TIB-Molbiol,
Berlin, Germany), 0.5 µM of primer CoxM9 (gcttcgtcccg-
gttcaacaattgc, nt 669–648) (TIB-Molbiol) and 2 µl of total
DNA. Thermal cycling involved 94°C for 9 min, followed
by 5 cycles of 94°C 30 s, 75°C to 67°C 30 s with 2 °C dec-BMC Microbiology 2008, 8:77 http://www.biomedcentral.com/1471-2180/8/77
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rements per cycle, 77°C 30 s; and 37 cycles of 94°C 30 s,
65°C 30 s, 77°C 30 s with a final elongation step at 77°C
2 min. PCR products were visualized by gel electrophore-
sis on a standard 1% agarose gel stained with ethidium
bromide.
Sample preparation/real-time PCR assay
Total genomic DNA was extracted manually using the
QIAmp DNA Minikit (Qiagen, Hilden, Germany) from
aliquots of homogenized samples as described above.
One hundred microliters of sample was added to 100 µl
of buffer ATL (Qiagen). Twenty microliters of Qiagen Pro-
teinase K were added, and incubated at 56°C for 30 min.
Next 200 µl of buffer AL (Qiagen) was added, which was
previously spiked with the C. burnetii internal control
plasmid at a final concentration of 20 copies per PCR reac-
tion. Further recommendations of the manufacturer were
followed (200 µl elution volume). Alternatively, genomic
DNA was extracted by an automated procedure using the
BioRobot M48 (Qiagen) in combination with a MagAt-
tract DNA Mini Kit (Qiagen). One hundred microliters of
sample were added to 100 µl buffer G2 (Qiagen) to which
the internal control was previously added at a concentra-
tion corresponding to 20 copies per PCR reaction. Ten
microliters of Proteinase K solution (Qiagen) were added
and incubated at 56°C for 30 min. Further procedure was
as recommended by the manufacturer, setting the elution
volume to 200 µl.
Plasmid standard (pCoxquant)
An 86 bp insert of the transposase gene of C. burnetii was
ligated into plasmid vectors and cloned in E. coli by means
of a pCR2.1-TOPO TA cloning kit (Invitrogen, Karlsruhe,
Germany). Plasmids were purified with a NucleoSpin
Plasmid kit (Macherey Nagel, Düren, Germany) and
sequenced using the BigDye 3.1 terminator cycle sequenc-
ing chemistry (Applied Biosystems, Weiterstadt, Ger-
many) on an automatic ABI 377 DNA sequencer (Applied
Biosystems). Plasmid DNA content was measured spec-
trophotometrically.
Internal control plasmid (pCoxmimic)
The C. burnetii plasmid pCoxquant was used to generate
an internal control plasmid. Gene splicing by overlap
extension was carried out using primers IcS
(atcgttcgttgagcgattagcagttgccaatttaaatcgtgatgccggat) and
IcAs (aactgctaatcgctcaacgaacgatgcaaggttgatgcttatcgggctatc)
to introduce an alternative probe-binding site at nucle-
otide positions 1266–1293 (GenBank accession
M80806). Resulting constructs of the correct length were
cloned by means of a pCR 2.1-TOPO TA cloning kit (Inv-
itrogen) and processed as described above.
Oligonucleotide design
Using primer Express software with default settings for
5'nuclease (TaqMan) minor groove binder (MGB) probes
(Applied Biosystems) two possible primer combinations
and one probe were evaluated. GenBank accession
M80806 served as the query sequence. The optimal
primer/probe combination was experimentally deter-
mined by checkerboard titration first. In a next set of
experiments individual primer concentration was opti-
mized and finally the magnesium concentration adjusted.
Real-time 5'nuclease PCR
A 25 µl reaction volume contained 5 µl of DNA, 4 mM
MgCl2, 1× Platinum Taq polymerase reaction buffer (Inv-
itrogen), 200 µM of each dNTP, 0.8 µM primer CoxbS
(gatagcccgataagcatcaac, nt position 1241–1261, GenBank
accession M80806) (TIB-Molbiol), 0.8 µM primer CoxbAs
(gcattcgtatatccggcatc, nt 1326–1307) (TIB-Molbiol), 0.3
µM probe CoxbMGB (tcatcaaggcaccaat, nt 1272–1287),
0.2  µM probe prCoxmutant (atcgttcgttgagcgattagcagtt)
and 1 unit of Taq DNA polymerase. 5'nuclease probe
CoxbMGB was labeled with 5'FAM and a 3' minor groove
binder non-fluorescent quencher (Applied Biosystems),
5'nuclease probe prCoxmutant was labeled with 5'VIC
and 3'Black Hole Quencher (Eurogentec, Seraing, Bel-
gium). Cycling conditions in an ABI Prism 7000 machine
(Applied Biosystems) were: 95°C/2 min, and 45 cycles of
95°C/15 sec, 60°C/30 sec. Data were analyzed with the
Sequence detector software V 2.1 (Applied Biosystems).
Specificity panel
Bacillus cereus (ATCC 4313), Bacillus subtilis (ATCC 6633),
Candida albicans (ATCC 10231), Chlamydophila pneumo-
niae (CWL-029H), Enterococcus faecalis (in house reference
strain), Epstein-Barr virus (patient isolate), Escherichia coli
(ATCC 25922), Hepatitis B virus (INSTAND ref. material
11019), Hepatitis C virus (1st International WHO NAT
standard), Human cytomegalovirus (INSTAND ref. mate-
rial 15005), Herpes simplex virus type 1 (INSTAND ref.
material 13017), Human immunodefieciency virus type 1
(NL-43),  Mycobacterium tuberculosis (in house reference
strain), Orientia tsutsugamushi (in house reference strain),
Plasmodium falciparum (patient isolate), Pseudomonas
aerogenosa (in-house reference strain), Rickettsia conorii (in
house reference strain), Rickettsia prowazeckii (in house
reference strain), Rickettsia rickettsii (in house reference
strain), Salmonella enteritidis (in house reference strain),
Shigella sonnei (in house reference strain), Staphylococcus
aureaus (ATCC 13565), Streptococcus pneumoniae (ATCC
6305), Streptococcus pyogenes (ATCC 19615)
Statistical analysis
Different input concentrations of C. burnetii plasmid DNA
pCoxquant were tested to calculate the predicted propor-
tion of positive results in replicate tests using probit anal-Publish with BioMed Central    and   every 
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ysis as a non-linear regression model. Statgraphics plus
version 5.1 software was used for probit analysis (Manu-
gistics, Dresden, Germany).
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